Latest ACE inhibitors Stories
Two seemingly similar blood pressure–lowering drugs have different effects on the heart health of dialysis patients.
One study presented at the meeting, which is being held in Budapest, Hungary, 7 to 10 December, reports on an initiative using echocardiography to document early warning signs of adverse effects from trastuzumab (Herceptin ®)¹, while the other uses echocardiography to evaluate the protective role of ACE inhibitors and statins on the hearts of cancer patients².
BALTIMORE, July 6, 2011 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration (US FDA) has granted final approval for its Amlodipine / Benazepril 5mg/40mg, and 10mg/40mg capsules. Commercial shipments of the product have already commenced.
The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients.
A drug used to treat high blood pressure may reduce the risk of kidney failure in obese patients.
Elderly patients prescribed combination angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) had a higher risk of kidney failure and death.
WOODCLIFF LAKE, N.J., Jan. 3, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it began shipping all strengths of amlodipine besylate and benazepril hydrochloride capsules, the generic version of Novartis' LotrelÂ®.
MORRISTOWN, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.
BURLINGTON, Mass., Sept.
- The governor of a province or people.